FDA to face questions about CBD rules from key congressional committee
The U.S. House Oversight Committee plans to grill Food and Drug Administration Commissioner Robert Califf about why the…
News January 17
Latest In: FDA
FDA dings American Shaman, four others for ‘illegally selling’ CBD
The U.S. Food and Drug Administration flagged five companies for “illegally selling” products containing cannabidiol, including national CBD…
News November 23
Vireo partners with medical school to conduct pioneering cannabis research at a low cost
The goal of a cannabis research study doesn’t always have to be the creation of a drug approved…
News July 1
FDA takes another look at CBD, but insiders are skeptical much will change
U.S. health regulators are taking their closest look in more than three years at the idea of incorporating…
News June 14
FDA issues first-ever warning letters on delta-8 THC
U.S. health authorities issued their first-ever warning letters about delta-8 THC Wednesday, saying the hemp-derived isomer "has psychoactive…
News May 4
Pros and cons of moving marijuana from Schedule 1 on the list of controlled substances
The absurdity of federal marijuana policy in the United States is perhaps best symbolized by the placement of…
News March 1
FDA approves GW Pharmaceuticals’ cannabis drug for new indication
CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a…
News August 3
DEA removes cannabis drug Epidiolex from controlled substances list
Epidiolex, the only plant-derived cannabis drug approved by the U.S. Food and Drug Administration, is no longer considered…
News April 7
The future of the medical marijuana industry: Q&A with Andrea Small-Howard, chief science officer at GB Sciences
Andrea Small-Howard has a unique view into how the medical side of the cannabis space is evolving. She’s…
News December 12Featured
1
Latest Sponsored
